SynthesisFrontiers in immunology2025
The addition of CD38 monoclonal antibody to triplet regimens improves survival in newly diagnosed multiple myeloma with high-risk cytogenetics: a systematic review and meta-analysis of randomized controlled trials.
Bin Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.